Hydrochloric Acid

Hydrochloric Acid

SCHEMBL262539

CCCCN(CCCC)c1cc[n+](CC(C)(C)C)cc1.[Cl-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 known ✓ P08172 1/20 0.43
CHRM1 known ✓ P11229 1/20 0.43
CHRM3 known ✓ P20309 1/20 0.43
ACHE known ✓ P22303 2/20 0.32
CHRM4 P08173 1/20 0.43
CHRM5 P08912 1/20 0.43
NR1H2 P55055 5/20 0.35
NR1H3 Q13133 5/20 0.35
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
MAPT P10636 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
KMT2A Q03164 1/20 0.34
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
HTT P42858 2/20 0.33
CHKA P35790 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9835086 0.98 CHRM2 (0.44) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL9330832 0.97 CHRM2 (0.46) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL9330040 0.94 MEN1 (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL9834006 0.92 MEN1 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
Bromide SCHEMBL9330798 0.90 CHRM2 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL7063921 0.80 CHRM2 (0.55) CHRM2CHRM4CHRM5CHRM1CHRM3
Hydrochloric Acid SCHEMBL5143850 0.74 CHKA (0.53) MAPTHTTCHKANPC1LMNA
SCHEMBL7153351 0.73 EGFR (0.50) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL34468104 0.72 CHKA (0.55) HTTCHKANPC1LMNARAB9A
Hydrochloric Acid SCHEMBL6687261 0.72 CHRM2 (0.40) CHRM2CHRM4CHRM5CHRM1CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060205958-A1 Direct dianhydride synthesis GENERAL ELECTRIC COMPANY 2006-09-14 US claimed
EP-0252964-B1 CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING SUBSTITUTED PYRIDINIUM SALTS MALLINCKRODT SPECIALTY CHEMICALS COMPANY (US) 1991-08-21 EP claimed
US-4973772-A Catalytic method for producing fluoroarmatic compounds using substituted pyridinium salts MALLINCKRODT, INC. (US) 1990-11-27 US claimed
EP-2280963-B1 METHOD OF PURIFYING DIANHYDRIDES, THE DIANHYDRIDES FORMED THEREBY, AND POLYETHERIMIDES FORMED THEREFROM SABIC GLOBAL TECHNOLOGIES BV (NL) 2016-07-20 EP disclosed
EP-2097375-B1 METHOD FOR PURIFYING BISIMIDES SABIC INNOVATIVE PLASTICS IP (NL) 2013-04-24 EP disclosed
EP-2089348-B1 METHOD FOR MAKING POLYETHERIMIDES SABIC INNOVATIVE PLASTICS IP (NL) 2013-02-20 EP disclosed
US-8134016-B2 Method for purifying dianhydrides SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2012-03-13 US disclosed
US-8013173-B2 Method of purifying dianhydrides, the dianhydrides formed thereby, and polyetherimides formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2011-09-06 US disclosed
EP-2094691-B1 METHOD FOR PURIFYING DIANHYDRIDES SABIC INNOVATIVE PLASTICS IP (NL) 2011-05-25 EP disclosed
EP-2280963-A1 METHOD OF PURIFYING DIANHYDRIDES, THE DIANHYDRIDES FORMED THEREBY, AND POLYETHERIMIDES FORMED THEREFROM SABIC Innovative Plastics IP B.V. (NL) 2011-02-09 EP disclosed
US-20090247727-A1 Method of Purifying Dianhydrides, the Dianhydrides Formed Thereby, and Polyetherimides Formed Therefrom SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2009-10-01 US disclosed
US-4916253-A Fluorobenzoates and process for their production IHARA CHEMICAL INDUSTRY COMPANY, LTD. (JP) 1990-04-10 US disclosed
EP-0321296-A1 Lipid derivatives their preparation and use SHIONOGI SEIYAKU KABUSHIKI KAISHA trading under the name of SHIONOGI & CO. LTD. (JP) 1989-06-21 EP disclosed
EP-0296479-A2 Fluorobenzoates and process for their production IHARA CHEMICAL INDUSTRY Co., Ltd. (JP) 1988-12-28 EP disclosed
EP-0252964-A4 CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING SUBSTITUTED PYRIDINIUM SALTS. MALLINCKRODT INC (US) 1988-07-14 EP disclosed
EP-0252964-A1 CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING SUBSTITUTED PYRIDINIUM SALTS. MALLINCKRODT INC (US) 1988-01-20 EP disclosed
WO-1987004150-A1 CATALYTIC METHOD FOR PRODUCING FLUOROAROMATIC COMPOUNDS USING SUBSTITUTED PYRIDINIUM SALTS MALLINCKRODT, INC. (US) 1987-07-16 WO disclosed
US-4605745-A PHASE TRANSFER CATALYSTS; AROMATIC ETHERS IN IMPROVED YIELDS GENERAL ELECTRIC COMPANY (US) 1986-08-12 US disclosed
US-4513141-A BY DISPLACING REACTIVE RADICALS ON AROMATIC NUCLEUS GENERAL ELECTRIC COMPANY (US) 1985-04-23 US disclosed
EP-0126950-A2 Method for making aromatic ethers and catalyst used in such method GENERAL ELECTRIC COMPANY (US) 1984-12-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060205958-A1 Direct dianhydride synthesis HDHD5, DOHH, DBH CHRM2 4458/4885CHRM1 4363/4885CHRM3 4537/4885
US-20090247727-A1 Method of Purifying Dianhydrides, the Dianhydrides Formed Thereby, and Polyetherimides Formed Therefrom CA7, CA4, CA13 CHRM2 3933/4885CHRM1 4443/4885CHRM3 4306/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.